Compare TKNO & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TKNO | RWAY |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.1M | 284.1M |
| IPO Year | 2021 | 2015 |
| Metric | TKNO | RWAY |
|---|---|---|
| Price | $7.43 | $6.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 255.4K | ★ 627.2K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 21.54% |
| EPS Growth | ★ 43.86 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $40,520,000.00 | N/A |
| Revenue This Year | $8.27 | $1.26 |
| Revenue Next Year | $13.13 | $1.25 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.35 | N/A |
| 52 Week Low | $1.91 | $5.19 |
| 52 Week High | $7.84 | $10.92 |
| Indicator | TKNO | RWAY |
|---|---|---|
| Relative Strength Index (RSI) | 68.89 | 58.22 |
| Support Level | $4.87 | $6.43 |
| Resistance Level | $7.84 | $6.61 |
| Average True Range (ATR) | 0.63 | 0.18 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 85.10 | 62.28 |
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States. The company's investment objective is to maximize its total return to its stockholders through current income on its loan portfolio, and secondarily through capital gain on its warrants and other equity positions.